Showing results (1961-1970 of 5,261) with videos related to

Sort By:
Pageof 527
Oncology|January 18, 2012
A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcomeAristotle Bamias, Christina Bamia, Alexandra Karadimou, et al.
Oncology|March 24, 2012
The clinical effect of the inhibitor of apopotosis protein livin in melanomaItay Lazar, Riki Perlman, Michal Lotem, et al.
Oncology|March 22, 2012
Plasma diamine oxidase activity is a useful biomarker for evaluating gastrointestinal tract toxicities during chemotherapy with oral fluorouracil anti-cancer drugs in patients with gastric cancerTsutomu Namikawa, Ian Fukudome, Hiroyuki Kitagawa, et al.
Oncology|March 22, 2012
HER2/neu may not be an interesting target in biliary cancers: results of an early phase II study with lapatinibJoshua Peck, Lai Wei, Mark Zalupski, et al.
Oncology|January 1, 1990
Clinical correlations with chemosensitivities measured in a simplified tritiated thymidine incorporation assay in patients with malignant effusionT Akiyoshi, T Wada, Y Nakamura
Oncology|January 1, 1990
Studies on the antineoplasticity of Schiff bases containing 5-nitrofuran and pyrimidineB Sur, S P Chatterjee, P Sur, et al.
Oncology|January 1, 1979
Serum lipids in hepatomaE A Alsabti
Oncology|April 18, 2012
Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancerSelja Koskensalo, Jaana Hagström, Johanna Louhimo, et al.
Oncology|April 18, 2012
Development of nanoaptamers using a mesoporous silica model labeled with (99m)tc for cancer targetingLucas Torres Miranda Sá, Claudia Pessoa, Assuero Silva Meira, et al.
Oncology|January 1, 1986
Demonstration of Epstein-Barr virus in malignant non-Hodgkin's lymphomasP Wutzler, I Färber, A Sauerbrei, et al.
Pageof 527